Two deputy directors at the Food and Drug Administration (FDA) who oversee the regulation of cancer drugs are reportedly planning to leave the agency, according to sources familiar with the…

Subscribe Now for Real-time Updates on the Latest Stories!
Artificial intelligence (AI) is revolutionizing healthcare in ways that were once only imagined in science fiction movies. While the futuristic…
Medline, a leading medical supplies firm, is gearing up for a blockbuster IPO worth up to $55 billion this winter.…
The American Society of Hematology (ASH) meeting is a crucial event in the world of biotechnology and drug development. This…
The Advisory Committee on Immunization Practices made a significant decision last week that could impact the way childhood vaccines are…
The ongoing debate surrounding vaccine regulation and development has taken a new turn with proposed changes to FDA standards. The…
Health and Human Services (HHS) has recently unveiled an AI strategy aimed at transforming agency operations to enhance efficiency, drive…
The use of GLP-1s for diabetic cats is gaining traction among veterinarians, with some already incorporating this treatment into their…
Obamacare Enrollment Lags Behind Last Year’s Record Pace Enrollment in individual coverage under the Affordable Care Act, also known as…
Sign in to your account